(Q44228019)

1 December 2017

title

Effects of postmenopausal hormone replacement therapy on insulin resistance (English)

1 reference

postmenopausal hormone-replacement therapy

1 December 2017

1 reference

1 reference

1 reference

Kenan Saglam

1

1 reference

1 December 2017

Zülfikar Polat

2

1 reference

1 December 2017

M Ilker Yilmaz

3

1 reference

1 December 2017

Mustafa Gulec

4

1 reference

1 December 2017

Seda B Akinci

5

1 reference

1 December 2017

publication date

1 August 2002

1 reference

1 December 2017

1 reference

1 December 2017

volume

18

1 reference

1 December 2017

issue

3

1 reference

1 December 2017

page(s)

211-214

1 reference

https://scigraph.springernature.com/pub.10.1385/endo:18:3:211

1 December 2017

exact match

0 references

cites work

Cellular insulin action and insulin resistance

1 reference

12 December 2020

Glucose tolerance, plasma insulin, HDL cholesterol and obesity: 12-year follow-up and development of coronary heart disease in Edinburgh men

1 reference

12 December 2020

Influence of age and menopause on serum lipids and lipoproteins in healthy women.

1 reference

12 December 2020

Hormone replacement therapy and blood pressure in hypertensive women.

1 reference

12 December 2020

Effect of hormone replacement therapy including a progestin on insulin sensitivity and lipid profile in postmenopausal women

1 reference

12 December 2020

Effect of estrogen replacement therapy on insulin sensitivity of glucose metabolism and preresistance and resistance vessel function in healthy postmenopausal women.

1 reference

12 December 2020

Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women

1 reference

12 December 2020

Smoking is independently associated with high plasma insulin levels in nondiabetic men.

1 reference

12 December 2020

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

12 December 2020

Glycaemic control and hormone replacement therapy: implications of the Postmenopausal Estrogen/Progestogen Intervention (PEPI) study

1 reference

12 December 2020

Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women

1 reference

12 December 2020

17 beta-Estradiol prevents dysfunction of canine coronary endothelium and myocardium and reperfusion arrhythmias after brief ischemia/reperfusion.

1 reference

12 December 2020

Determination of Insulin Sensitivity: Methodological Considerations

1 reference

12 December 2020

Research on coronary disease in women: political or scientific imperative?

1 reference

12 December 2020

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

1 reference

12 December 2020

Hormone replacement therapy in postmenopausal women with diabetes mellitus: a risk-benefit assessment

1 reference

12 December 2020

The independent effects of exercise and estrogen on lipids and lipoproteins in postmenopausal women.

1 reference

12 December 2020

Insulin resistance and lipids in hypertensive women on hormone replacement therapy

1 reference

12 December 2020

Relationship between hormone replacement therapy use with body fat distribution and insulin sensitivity in obese postmenopausal women

1 reference

12 December 2020

Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women.

1 reference

12 December 2020

The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women

1 reference

12 December 2020

Identifiers

DOI

10.1385/ENDO:18:3:211

1 reference

Dimensions Publication ID

1 December 2017

1037695188

0 references

1 reference